Eva Chatron
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
-
- Cystic Fibrosis Research Advances 3
- Oncology 2
- Viral-associated cancers and disorders 1
- COVID-19 and healthcare impacts 1
- Co-authors
- Romain Kessler (6 shared papers)Julie Mankikian (1 shared paper)R. Chiron (1 shared paper)Laurence M. Weiss (2 shared papers)S. Dominique (1 shared paper)Sandrine Touzet (1 shared paper)Michel Abély (2 shared papers)Françoise Troussier (1 shared paper)
- Journals
- Journal of Cystic Fibrosis (3 papers)Clinical Transplantation (2 papers)EClinicalMedicine (1 paper)European Journal of Clinical Investigation (1 paper)JAMA Internal Medicine (1 paper)
- Partner nations
- FranceUnited States
In The Last Decade
Eva Chatron
11 papers receiving 901 citations
Eva Chatron's Hit Papers
Peers
Comparison fields: 5 of 76
- Infectious Diseases 575
- Neurology 294
- Critical Care and Intensive Care Medicine 32
- Applied Microbiology and Biotechnology 8
- Pulmonary and Respiratory Medicine 107
Countries citing papers authored by Eva Chatron
This map shows the geographic impact of Eva Chatron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Chatron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Chatron more than expected).
Fields of papers citing papers by Eva Chatron
This network shows the impact of papers produced by Eva Chatron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Chatron. The network helps show where Eva Chatron may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Chatron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia Hit paper breakdown → | 2020 | 589 |
| 2 | Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial Hit paper breakdown → | 2021 | 229 |
| 3 | 2020 | 55 | |
| 4 | 2021 | 13 | |
| 5 | 2020 | 13 | |
| 6 | 2018 | 9 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 4 | |
| 9 | 2020 | 2 | |
| 10 | 2018 | 1 | |
| 11 | 2024 | 1 | |
| 12 | 2019 | 0 | |
| 13 | 2026 | 0 |
About Eva Chatron
Eva Chatron is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Obstetrics and Gynecology, Genetics and Neurology, having authored 13 papers that have together received 921 indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (3 papers), Transplantation: Methods and Outcomes (2 papers), COVID-19 Clinical Research Studies (1 paper), Immunodeficiency and Autoimmune Disorders (1 paper), Viral-associated cancers and disorders (1 paper), Lymphoma Diagnosis and Treatment (1 paper), COVID-19 and healthcare impacts (1 paper) and COVID-19 Impact on Reproduction (1 paper). The work is most often cited by research in Infectious Diseases (575 citations), Neurology (294 citations), Critical Care and Intensive Care Medicine (32 citations), Applied Microbiology and Biotechnology (8 citations) and Pulmonary and Respiratory Medicine (107 citations). Eva Chatron has collaborated with scholars based in France and United States. Frequent co-authors include Romain Kessler, Julie Mankikian, R. Chiron, Laurence M. Weiss, S. Dominique, Sandrine Touzet, Michel Abély, Françoise Troussier, Laure Cosson and Quitterie Reynaud. Their work appears in journals such as Journal of Cystic Fibrosis, Clinical Transplantation, EClinicalMedicine, European Journal of Clinical Investigation and JAMA Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.